Comparative Pharmacology
Head-to-head clinical analysis: CORDARONE versus SOTALOL HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORDARONE versus SOTALOL HYDROCHLORIDE.
CORDARONE vs SOTALOL HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Class III antiarrhythmic agent; prolongs action potential duration and refractory period via blockade of potassium channels; also exhibits class I, II, and IV properties including sodium channel blockade, non-competitive beta-adrenergic blockade, and calcium channel blockade.
Sotalol is a non-selective beta-adrenergic receptor antagonist (beta-blocker) with additional class III antiarrhythmic activity (prolongation of cardiac action potential duration via blockade of potassium channels). It decreases heart rate, myocardial contractility, and AV conduction velocity, and increases ventricular refractoriness.
Loading dose: 800-1600 mg/day orally in divided doses for 1-3 weeks, then 600-800 mg/day for 1 month, then maintenance: 200-400 mg/day. IV: Loading 150 mg over 10 minutes, then 1 mg/min for 6 hours, then 0.5 mg/min.
Initial: 80 mg orally twice daily; may increase every 3 days to 160-320 mg/day, maximum 640 mg/day (for life-threatening arrhythmias). Also available as 80 mg intravenous over 20 minutes (1.5 mg/kg) for acute management.
None Documented
None Documented
Terminal half-life ranges 40–70 days (mean 55 days) due to extensive tissue accumulation, particularly in adipose tissue. Prolonged half-life necessitates loading doses and long washout periods.
Terminal elimination half-life: 10-20 hours in normal renal function; prolonged in renal impairment (up to 40 hours), requiring dose adjustment.
Primarily hepatic metabolism with biliary excretion; minimal renal elimination (<1% unchanged). Fecal excretion accounts for ~70% of the dose. Less than 10% excreted in urine.
Renal: 80-90% unchanged via glomerular filtration and tubular secretion; biliary/fecal: <20%.
Category C
Category A/B
Antiarrhythmic (Class III)
Antiarrhythmic (Class III)